Wellness
Addressing barriers to advance care planning by adults with advanced cancers

Researchers have found that mindfulness showed promise in improving quality of life and advance care planning outcomes in patients and their family caregivers coping with advanced cancer.
Both patients with poor cancer prognoses and family caregivers often use avoidant coping strategies, such as delaying advance care planning discussions.
Mindfulness emphasizes paying attention to the present moment with an attitude of openness, compassion and interested curiosity accomplished through meditation and other exercises to manage stress.
In a randomised controlled trial, mindfulness training tailored to the needs of cancer patients improved psychological well-being and self-confidence for advance care planning for patients. For caregivers, mindfulness training supported improvements in quality of life at follow-up.
The two-arm study blended mindfulness skills training with advance care planning education to address emotional barriers to advance care planning and contrasted it with usual care which included no coping training or tools.
To help patients clarify their values and goals regarding the kind of care that they want to receive, if and when their disease progresses, and to help caregivers if the patient becomes unable to make medical decisions, the intervention was delivered in six two-hour group sessions enabling patients and caregivers to interact and share experiences. These study participants also received resources to practice mindfulness at home.
Study senior author Shelley Johns of the Regenstrief Institute said: “Drawing upon many years of working in clinical practice with adults facing advanced cancer and their family caregivers, I had noticed considerable avoidant coping that was preventing patients from sharing their thoughts, feelings, and care preferences with their family caregivers.
“This avoidance seemed to be increasing stress for both patients and caregivers and interfering with quality of life. When we guided patients and family caregivers in mindfulness practices and offered skills they could use to have these tender conversations with greater ease, they became more receptive to making decisions.
“Mindfulness is about noticing what’s here so we can choose the wisest response and hopefully be less emotionally reactive.
“Mindfulness practices help individuals increase their mindfulness muscle, so to speak. Anything that we do in our life, from brushing our teeth to having a conversation with a loved one, can be done with mindful focus, with mindful attention.
“Medical care is understandably focused on the patient — and family caregivers often feel left out. In this study, caregivers and patients were both centre stage and I think that’s why the caregivers of these patients, as well as the patients themselves, were so interested in mindfulness.
“The caregivers were looking for tools, resources, skills and opportunities to learn something that could be of use to them in supporting their family member who had a diagnosis with a poor prognosis.”
Participants were 55 family caregivers and 55 adults with advanced solid malignancies including breast, prostate, lung and colorectal cancers, many of whose long-term treatments were no longer achieving desired results.
“Mindfulness can help adults be more fully focused on the present and can address the emotional barriers to advance care planning, bringing peace of mind knowing their medical decisions are known to both their caregiver and their medical team,” said corresponding author Catherine Mosher, professor of psychology at the School of Science at IU Indianapolis.
“The take-home message from this study is that mindfulness practices can be a supportive resource for dealing with the realities of life that come with advanced stage cancer, whether you are the patient or the family caregiver,” added co-author Susan Hickman.
“Ongoing conversations about goals, values and preferences are essential to help prepare patients and their caregivers for end-of-life decision-making.”
News
Gut-friendly foods may damage heart, charity warns
News
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.












